Calliditas Therapeutics
Calliditas Q3: Approching an important milestone (Redeye)

2019-11-14 10:36
Calliditas' report for the third quarter included no surprises. The 200 patients required for top-line readout are expected to be fully recruited before the end of the year, which should enable top-line readout of the study in late 2020.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Calliditas Therapeutics - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -